# Global Longitudinal Strain Alteration of the Left Ventricle in Children with Organic Aciduria: Cardiac Disease in Organic Aciduria

**Authors:** Bastien Moysset, Célia Hoebeke, Brigitte Chabrol, Guillaume Carles, Beatrice Desnous, Julie Delphine Blanc, Caroline Ovaert, Fedoua El Louali

PMC · DOI: 10.3390/jcm15041393 · Journal of Clinical Medicine · 2026-02-10

## TL;DR

This study shows that children with propionic acidemia may have early heart issues detected by strain measurements, even when heart function appears normal.

## Contribution

The study introduces LV GLS as a potential early marker for cardiac dysfunction in propionic acidemia.

## Key findings

- LV GLS was significantly lower in PA patients compared to MMA patients.
- PA patients had significantly lower LV GLS than the general pediatric population.
- LVEF was normal in both PA and MMA patients.

## Abstract

Introduction: Cardiac complications are well-documented in propionic acidemia (PA), and there are a few reported cases of cardiomyopathies in methylmalonic acidemia (MMA). Left-ventricular global longitudinal strain (LV GLS) measurement is known to be able to detect early ventricular dysfunction, leading potentially to cardiomyopathy. The aim of our study was to evaluate left-ventricular global longitudinal strain (LV GLS) in MMA and PA patients and compare it with the pediatric general population. Methods: In this monocentric retrospective study, 26 patients with organic aciduria (OA) were included. Demographic, clinical, electrocardiographic and echocardiographic data were collected. The mean LV GLS in MMA and PA patients was compared with the GLS in the pediatric general population. Results: The left-ventricular ejection fraction (LVEF) was similar between MMA and PA patients and in the normal range (66.27 ± 6.24% vs. 61.41 ± 11.02%; p = 0.182). LV GLS was significantly lower in PA patients than in MMA patients (−15.8 ± 5.67% vs. −20.6 ± 3.19%; p = 0.011). LV GLS was significantly lower in PA patients when compared with the general pediatric population (p = 0.029). Conclusions: Patients with propionic acidemia may have impaired global longitudinal strain even in the presence of normal LVEF. LV GLS might be a useful tool for cardiac follow-up in pediatric patients with OA.

## Linked entities

- **Diseases:** propionic acidemia (MONDO:0011628), methylmalonic acidemia (MONDO:0002012), cardiomyopathy (MONDO:0004994)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** MMUT (methylmalonyl-CoA mutase) [NCBI Gene 4594] {aka MCM, MUT}, NPPB (natriuretic peptide B) [NCBI Gene 4879] {aka BNP, Iso-ANP}, REN (renin) [NCBI Gene 5972] {aka ADTKD4, HNFJ2, RTD}
- **Diseases:** cancer (MESH:D009369), dilated and hypertrophic cardiomyopathy (MESH:D002311), dyspnea (MESH:D004417), cardiovascular toxicity (MESH:D002318), pancreatitis (MESH:D010195), ventricular dysfunction (MESH:D018754), toxicity (MESH:D064420), methyl malonic acidemia (MESH:C535702), Organic propionic and methylmalonic acidurias (MESH:D056693), injury to (MESH:D014947), coenzyme Q10 deficiency (MESH:C564403), dysfunction of mitochondrial metabolism (MESH:D028361), left-ventricular (LV) hypertrophy (MESH:D017379), supraventricular or ventricular tachycardia (MESH:D013617), AO (MESH:C535396), cardiac death (MESH:D003643), hereditary metabolic pathologies (MESH:D009386), deficiency (MESH:D007153), deficiency of cobalamin (MESH:C564747), aLQTS (MESH:D008133), arrhythmic and myocardial (OMIM:212500), atrial extrasystoles (MESH:D018880), Duchenne or Becker muscular dystrophy (MESH:D020388), metabolic derangement (MESH:D008659), ventricular extrasystole (MESH:D018879), ventricular fibrillation (MESH:D014693), autosomal recessive diseases (MESH:D030342), LVEF (MESH:D054144), cognitive impairment (MESH:D003072), impaired LVEF (MESH:D054143), systole (MESH:D000092244), movement disorders (MESH:D009069), congestive heart failure (MESH:D006333), organ dysfunction (MESH:D009102), arrhythmia (MESH:D001145), OAs (MESH:D000092124), kidney disease (MESH:D007674), left-ventricular dysfunction (MESH:D018487), of myocardial function (OMIM:300082), homo-cystinuria (MESH:D003555), MMA (MESH:C537358), stroke (MESH:D020521), Cardiac complications (MESH:D006331), cardiac subclinical anomalies (MESH:D058345), fatigue (MESH:D005221), chest pain (MESH:D002637), CM (MESH:D009202), myopathy (MESH:D009135), LV systolic dysfunction (MESH:D020257)
- **Chemicals:** amino acid (MESH:D000596), isoleucine (MESH:D007532), ammonium (MESH:D064751), coenzyme Q10 (MESH:C024989), methylmalonic acid (MESH:D008764), aldosterone (MESH:D000450), coenzyme A (MESH:D003065), Propionate (MESH:D011422), carbonic acids (MESH:D002255), free carnitine (-), methionine (MESH:D008715), L-carnitine (MESH:D002331), methyl citric acid (MESH:C031605), enalapril (MESH:D004656), threonine (MESH:D013912), 3-hydroxypropionic acid (MESH:C031601), valine (MESH:D014633), vitamin B12 (MESH:D014805)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12941125/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12941125/full.md

## References

59 references — full list in the complete paper: https://tomesphere.com/paper/PMC12941125/full.md

---
Source: https://tomesphere.com/paper/PMC12941125